GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) partner GSK Plc (NYSE:GSK) on Wednesday shared data from two pivotal Phase 3 studies, B-Well 1 and B-Well...
Here’s How Much You Would Have Made Owning Hilton Worldwide Holdings Stock In The Last 10 Years
Hilton Worldwide Holdings (NYSE:HLT) has outperformed the market over the past 10 years by 8.04% on an annualized basis producing an average annual...
Here’s How Much You Would Have Made Owning CSX Stock In The Last 10 Years
CSX (NASDAQ:CSX) has outperformed the market over the past 10 years by 2.58% on an annualized basis producing an average annual return of 16.17%....
$1000 Invested In Vanguard Russell 1000 Growth ETF 10 Years Ago Would Be Worth This Much Today
Vanguard Russell 1000 Growth ETF (NASDAQ:VONG) has outperformed the market over the past 10 years by 4.07% on an annualized basis producing an...
Why Morgan Stanley’s Bitcoin ETF Launch Is ‘Extremely Bullish’
Morgan Stanley's move to launch its own Bitcoin (CRYPTO: BTC) ETF is one of the most bullish developments for crypto and points to significant...
UniFirst Growth Strategy Hits Near-Term Profits
UniFirst Corp. (NYSE:UNF) announced its fiscal 2026 first-quarter results on Wednesday, and shares moved lower after the report as investors...
$1000 Invested In Futu Holdings 5 Years Ago Would Be Worth This Much Today
Futu Holdings (NASDAQ:FUTU) has outperformed the market over the past 5 years by 7.52% on an annualized basis producing an average annual return of...
Price Over Earnings Overview: BP
Looking into the current session, BP Inc. (NYSE:BP) shares are trading at $33.80, after a 1.63% decrease. Over the past month, the stock decreased...
Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 12.83% on an annualized basis producing an average...
Oklo Wins DOE Backing For Nuclear Pilot Targeting Cancer Care
Oklo Inc. (NYSE:OKLO) took a significant step forward in its long-term nuclear ambitions on Wednesday, securing fresh backing from the U.S....
If You Invested $1000 In Sherwin-Williams Stock 15 Years Ago, You Would Have This Much Today
Sherwin-Williams (NYSE:SHW) has outperformed the market over the past 15 years by 6.19% on an annualized basis producing an average annual return of...
Boeing Lands Massive Alaska Airlines Deal In Carrier’s Biggest Plane Order Ever
Boeing Co. (NYSE:BA) on Wednesday landed a landmark aircraft deal after Alaska Air Group, Inc. (NYSE:ALK) placed its largest order ever. Alaska said...
Here’s How Much $100 Invested In TransDigm Gr 5 Years Ago Would Be Worth Today
TransDigm Gr (NYSE:TDG) has outperformed the market over the past 5 years by 4.64% on an annualized basis producing an average annual return of...
Monte Rosa’s Experimental Drug Slashes Inflammation Linked To Heart Disease
Clinical-stage biotechnology company Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) on Wednesday revealed interim data from an ongoing Phase 1 study of...
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Wednesday. Shares of Monte Rosa Therapeutics Inc (NASDAQ:GLUE) rose sharply...